• レポートコード:MRC2-11QY11240 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、96ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は犬インフルエンザ治療薬のグローバル市場について調査・分析したレポートです。種類別(ワクチン、その他)市場規模、用途別(獣医クリニック、獣医病院、動物医療施設)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別犬インフルエンザ治療薬の競争状況、市場シェア ・世界の犬インフルエンザ治療薬市場:種類別市場規模 2015年-2020年(ワクチン、その他) ・世界の犬インフルエンザ治療薬市場:種類別市場規模予測 2021年-2026年(ワクチン、その他) ・世界の犬インフルエンザ治療薬市場:用途別市場規模 2015年-2020年(獣医クリニック、獣医病院、動物医療施設) ・世界の犬インフルエンザ治療薬市場:用途別市場規模予測 2021年-2026年(獣医クリニック、獣医病院、動物医療施設) ・北米の犬インフルエンザ治療薬市場分析:米国、カナダ ・ヨーロッパの犬インフルエンザ治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの犬インフルエンザ治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の犬インフルエンザ治療薬市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの犬インフルエンザ治療薬市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Merck & Co、Intervet、Zoetis Services ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus.
Market Analysis and Insights: Global Canine Flu Therapeutics Market
The global Canine Flu Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Flu Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Flu Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Flu Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Flu Therapeutics market.
Global Canine Flu Therapeutics Scope and Market Size
Canine Flu Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Canine Flu Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Vaccines
Others
Market segment by Application, split into
Vet Clinics
Veterinary Hospitals
Animal Healthcare Facilities
Based on regional and country-level analysis, the Canine Flu Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Canine Flu Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Merck & Co
Intervet
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Flu Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Vaccines
1.2.3 Others
1.3 Market by Application
1.3.1 Global Canine Flu Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Vet Clinics
1.3.3 Veterinary Hospitals
1.3.4 Animal Healthcare Facilities
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Canine Flu Therapeutics Market Perspective (2015-2026)
2.2 Global Canine Flu Therapeutics Growth Trends by Regions
2.2.1 Canine Flu Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Canine Flu Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Canine Flu Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Flu Therapeutics Players by Market Size
3.1.1 Global Top Canine Flu Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Canine Flu Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Canine Flu Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Flu Therapeutics Revenue
3.4 Global Canine Flu Therapeutics Market Concentration Ratio
3.4.1 Global Canine Flu Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Flu Therapeutics Revenue in 2019
3.5 Key Players Canine Flu Therapeutics Area Served
3.6 Key Players Canine Flu Therapeutics Product Solution and Service
3.7 Date of Enter into Canine Flu Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Flu Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Canine Flu Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Canine Flu Therapeutics Forecasted Market Size by Type (2021-2026)
5 Canine Flu Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Canine Flu Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Canine Flu Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Canine Flu Therapeutics Market Size (2015-2026)
6.2 North America Canine Flu Therapeutics Market Size by Type (2015-2020)
6.3 North America Canine Flu Therapeutics Market Size by Application (2015-2020)
6.4 North America Canine Flu Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Canine Flu Therapeutics Market Size (2015-2026)
7.2 Europe Canine Flu Therapeutics Market Size by Type (2015-2020)
7.3 Europe Canine Flu Therapeutics Market Size by Application (2015-2020)
7.4 Europe Canine Flu Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Canine Flu Therapeutics Market Size (2015-2026)
8.2 China Canine Flu Therapeutics Market Size by Type (2015-2020)
8.3 China Canine Flu Therapeutics Market Size by Application (2015-2020)
8.4 China Canine Flu Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Canine Flu Therapeutics Market Size (2015-2026)
9.2 Japan Canine Flu Therapeutics Market Size by Type (2015-2020)
9.3 Japan Canine Flu Therapeutics Market Size by Application (2015-2020)
9.4 Japan Canine Flu Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Canine Flu Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Canine Flu Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Canine Flu Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Canine Flu Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Details
11.1.2 Merck & Co Business Overview
11.1.3 Merck & Co Canine Flu Therapeutics Introduction
11.1.4 Merck & Co Revenue in Canine Flu Therapeutics Business (2015-2020))
11.1.5 Merck & Co Recent Development
11.2 Intervet
11.2.1 Intervet Company Details
11.2.2 Intervet Business Overview
11.2.3 Intervet Canine Flu Therapeutics Introduction
11.2.4 Intervet Revenue in Canine Flu Therapeutics Business (2015-2020)
11.2.5 Intervet Recent Development
11.3 Zoetis Services
11.3.1 Zoetis Services Company Details
11.3.2 Zoetis Services Business Overview
11.3.3 Zoetis Services Canine Flu Therapeutics Introduction
11.3.4 Zoetis Services Revenue in Canine Flu Therapeutics Business (2015-2020)
11.3.5 Zoetis Services Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Canine Flu Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Vaccines
Table 4. Key Players of Others
Table 5. Global Canine Flu Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Canine Flu Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Canine Flu Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Canine Flu Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Canine Flu Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Canine Flu Therapeutics Market Share by Regions (2021-2026)
Table 11. Canine Flu Therapeutics Market Market Trends
Table 12. Canine Flu Therapeutics Market Drivers
Table 13. Canine Flu Therapeutics Market Challenges
Table 14. Canine Flu Therapeutics Market Restraints
Table 15. Global Canine Flu Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Canine Flu Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Canine Flu Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Flu Therapeutics as of 2019)
Table 18. Global Canine Flu Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Canine Flu Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Canine Flu Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Canine Flu Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Canine Flu Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Canine Flu Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Canine Flu Therapeutics Market Share by Type (2015-2020)
Table 30. North America Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Canine Flu Therapeutics Market Share by Application (2015-2020)
Table 32. North America Canine Flu Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Canine Flu Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Canine Flu Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Canine Flu Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Canine Flu Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Canine Flu Therapeutics Market Share by Country (2015-2020)
Table 40. China Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Canine Flu Therapeutics Market Share by Type (2015-2020)
Table 42. China Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Canine Flu Therapeutics Market Share by Application (2015-2020)
Table 44. China Canine Flu Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Canine Flu Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Canine Flu Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Canine Flu Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Canine Flu Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Canine Flu Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Canine Flu Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Canine Flu Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Canine Flu Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Canine Flu Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Canine Flu Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Canine Flu Therapeutics Market Share by Country (2015-2020)
Table 58. Merck & Co Company Details
Table 59. Merck & Co Business Overview
Table 60. Merck & Co Product
Table 61. Merck & Co Revenue in Canine Flu Therapeutics Business (2015-2020) (US$ Million)
Table 62. Merck & Co Recent Development
Table 63. Intervet Company Details
Table 64. Intervet Business Overview
Table 65. Intervet Product
Table 66. Intervet Revenue in Canine Flu Therapeutics Business (2015-2020) (US$ Million)
Table 67. Intervet Recent Development
Table 68. Zoetis Services Company Details
Table 69. Zoetis Services Business Overview
Table 70. Zoetis Services Product
Table 71. Zoetis Services Revenue in Canine Flu Therapeutics Business (2015-2020) (US$ Million)
Table 72. Zoetis Services Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Flu Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Vaccines Features
Figure 3. Others Features
Figure 4. Global Canine Flu Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Vet Clinics Case Studies
Figure 6. Veterinary Hospitals Case Studies
Figure 7. Animal Healthcare Facilities Case Studies
Figure 8. Canine Flu Therapeutics Report Years Considered
Figure 9. Global Canine Flu Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Canine Flu Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Canine Flu Therapeutics Market Share by Regions (2021-2026)
Figure 12. Global Canine Flu Therapeutics Market Share by Players in 2019
Figure 13. Global Top Canine Flu Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Flu Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Canine Flu Therapeutics Revenue in 2019
Figure 15. North America Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Canine Flu Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Merck & Co Revenue Growth Rate in Canine Flu Therapeutics Business (2015-2020)
Figure 43. Intervet Revenue Growth Rate in Canine Flu Therapeutics Business (2015-2020)
Figure 44. Zoetis Services Revenue Growth Rate in Canine Flu Therapeutics Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed